REQUEST A DEMO
Total
USD $0.00
Search more companies

Sterlife Pharma Private Limited (India)

Main Activities: Artificial and Synthetic Fibers and Filaments Manufacturing
Full name: Sterlife Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sterlife Pharma Private Limited is an unlisted company, incorporated on 02/05/2016. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24303GJ2016PTC091786 and registration number is 091786. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Pl No.90, R.S.No.3P-1 Vardhman Ind Park B/H.Kishan Dehydration,Opp.Capital Polyplast,Nh 27,Bhojpara
Rajkot; Gujarat; Postal Code: 360311

Contact Details: Purchase the Sterlife Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Sterlife Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Sterlife Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Sterlife Pharma Private Limited report to view the information.
Incorporation Date:
May 02, 2016
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Sterlife Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-18.81%
Total operating revenue
-18.95%
Operating profit (EBIT)
-48.61%
EBITDA
-35.94%
Net Profit (Loss) for the Period
-45.35%
Total assets
-9.85%
Total equity
20.35%
Operating Profit Margin (ROS)
-1.05%
Net Profit Margin
-0.67%
Return on Equity (ROE)
-20.32%
Debt to Equity Ratio
-152.84%
Quick Ratio
-0.07%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?